MRI fusion-based ultrasound-guided prostate biopsy

Compared to systematic ultrasound-guided re-biopsy, MRI-guided prostate punch biopsy has an approximately 40-50% higher detection rate with regard to the detection of clinically significant prostate cancer.

With MRI/US fusion biopsy, we can fuse the digital images of a prostate MRI of the patient (taken in the Department of Radiology/MHH) with the transrectal ultrasound images "live". This enables targeted puncture of suspicious areas that were previously marked by the radiologist using the MRI.

The MRI fusion-based prostate biopsy is performed both

- transrectally under local anesthesia (outpatient)
- transperineally under general anesthesia (1-2 days inpatient stay)

performed.

A discussion of the histopathological results and treatment options is then possible.

You can find detailed information in our flyer: TO FLYER